BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-2005 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-2005\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06108492-11097@assetmemo.bio
DTSTAMP:20261121T004538Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:SHR-2005: Phase 1 readout est. (NCT06108492)
DESCRIPTION:SHR-2005\, phase 1\, Bladder Cancer.\nStudy: A Phase I Clinical
  Study of SHR-2005 Intravesical Instillation in the Treatment of Intermedi
 ate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)\nEstimated pr
 imary completion: 31 December 2026. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/shr-2005#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT06108492
URL:https://assetmemo.bio/drug/shr-2005#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06588179-11097@assetmemo.bio
DTSTAMP:20261121T004538Z
DTSTART;VALUE=DATE:20271001
DTEND;VALUE=DATE:20271002
SUMMARY:SHR-2005: Phase 1/2 readout est. (NCT06588179)
DESCRIPTION:SHR-2005\, phase 1/2\, Bladder Cancer.\nStudy: SHR-1501 Combine
 d With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is 
 Not Completely Resectable by TURBt\nEstimated primary completion: 1 Octobe
 r 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/shr-2005#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT06588179
URL:https://assetmemo.bio/drug/shr-2005#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
